| Name | Title | Contact Details |
|---|
Klein Allen Co. is a American Fork, UT-based company in the Business Services sector.
JMH Education Marketing is a New York, NY-based company in the Business Services sector.
Dishon Limited is a North York, ON-based company in the Business Services sector.
GenomOncology is a precision oncology software company based in Cleveland, Ohio, founded in 2012. The company focuses on transforming complex clinical and molecular data into actionable insights to enhance cancer care. Its mission is to empower healthcare institutions to utilize data-driven decision-making tailored to the specific needs of precision oncology programs. The core offering is the Precision Oncology Platform (POP), which integrates proprietary algorithms and machine learning to analyze genetic test results and clinical data, providing treatment recommendations and clinical trial matching. Additionally, the GO Pathology Workbench supports germline testing workflows, allowing labs to efficiently validate and report genetic findings. GenomOncology also offers data integration services that combine internal patient data with external annotation sets to generate evidence-based insights. The company primarily serves hospitals, cancer centers, and laboratories looking for scalable tools for genomic data interpretation and therapy matching.
RISC-V International is the non-profit home of the open standard RISC-V Instruction Set Architecture (ISA), related specifications, and stakeholder community. With global membership across 70 different countries, over 4,200 members are contributing and collaborating to define RISC-V open specifications as well as convene and govern related technical, industry, domain, and special interest groups. RISC-V combines a modular technical approach with an open, royalty-free license model -- meaning that anyone, anywhere can leverage the IP contributed and produced by RISC-V. RISC-V enables the community to share technical investment, contribute to the strategic future, create more rapidly, enjoy unprecedented design freedom, and substantially reduce the cost of innovation.